Sodium removal per ultrafiltration volume in automated peritoneal dialysis in pediatric patients

Takashi Tokunaga(Naha City Hospital), Masataka Honda(Rikkyo University), Tomohiro Inoguchi(Tokyo Metropolitan Children's Medical Center), Naoaki Mikami(Tokyo Metropolitan Children's Medical Center), Chikako Terano(National Center For Child Health and Development), Riku Hamada, Kenji Ishikura(Kitasato University), Ryoko Harada(Tokyo Metropolitan Children's Medical Center), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Yuko Hamasaki(Toho University)
Pediatric Nephrology
May 2, 2024
10.1007/s00467-024-06383-9
Cited by 1

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135